Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion
NASDAQ:SLGL

Sol-Gel Technologies Q3 2026 Earnings Date & Estimates

Sol-Gel Technologies logo
$65.72 -0.09 (-0.14%)
Closing price 10/21/2026 04:00 PM Eastern
Extended Trading
$64.80 -0.92 (-1.40%)
As of 04:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sol-Gel Technologies is estimated to report Q3 2026 earnings on Thursday, November 19, 2026, before market opens.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Sol-Gel Technologies in Q3 2026

Sol-Gel Technologies is expected to post earnings of -$2.0745 per share on revenue of $0.15 million. In the same quarter a year earlier Sol-Gel Technologies reported -$2.13 per share on revenue of $0.40 million. Sol-Gel Technologies last reported on August 21, 2026, posting -$1.13 per share and beating the -$2.36 consensus estimate. Sol-Gel Technologies has beaten the consensus EPS estimate in 4 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$2.0745
Expected Revenue
$0.15 million
Prior-Year EPS
-$2.13
Prior-Year Revenue
$0.40 million
Expected Revenue Growth
-62.5%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$1.13 (Beat by +$1.23)
Last Quarter Revenue
$0.59 million
EPS Beat Rate
4 of last 8 quarters

Prepare for the Q3 2026 Call

Sol-Gel Technologies Q3 2026 Earnings FAQ

Sol-Gel Technologies (NASDAQ:SLGL) is estimated to report Q3 2026 earnings on Thursday, November 19, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Sol-Gel Technologies' Q3 2026 earnings conference call is scheduled for Monday, November 9, 2026 at 12:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Sol-Gel Technologies to post earnings of -$2.0745 per share for Q3 2026.

The consensus revenue estimate for Sol-Gel Technologies is $0.15 million for Q3 2026.

Sol-Gel Technologies Earnings Headlines

Sol-Gel Technologies (NASDAQ:SLGL) Given Buy Rating at HC Wainwright
October 19 at 8:07 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31134195
Cantor Fitzgerald Begins Coverage on Sol-Gel Technologies (NASDAQ:SLGL)
October 16, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31123632
Buffett's Final Warning: "The Dollar Is Going to Hell"
Do not buy another AI stock until you've seen the arithmetic below. Nvidia is worth about $5.5 trillion. Alphabet about $4.1 trillion. Microsoft about $3.8 trillion. So what would it take to repeat Nvidia's run? A 100x gain from here puts Nvidia near $550 trillion. Nothing in history has ever been worth that. Big money in Nvidia has already been made. By the people who bought it years ago. But that does not mean the AI boom is finished. It means the opportunity has moved underneath it... to the layer every AI company has to pay to use.tc pixel
October 22 at 1:00 AM  |  Decentralized Masters (Ad)
Cantor Fitzgerald initiates coverage of Sol-Gel Technologies at overweight
October 14, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/cantor-fitzgerald-initiates-coverage-of-sol-gel-technologies-at-overweight/ar-AA2eeZwt
Sol-Gel Technologies Ltd. (SLGL) Analyst/Investor Day Transcript
October 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4954240-sol-gel-technologies-ltd-slgl-analyst-investor-day-transcript
Sol-Gel Technologies consensus price target decreased by 22.46% to $155.55
October 2, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/sol-gel-technologies-consensus-price-target-decreased-by-2246-to-15555/ar-AA2dp5l1
See More Sol-Gel Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sol-Gel Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sol-Gel Technologies and other key companies, straight to your email.

About Sol-Gel Technologies

Sol-Gel Technologies (NASDAQ:SLGL) (NASDAQ: SLGL) is an Israeli specialty pharmaceutical company focused on developing and commercializing topical dermatological treatments. The company uses proprietary silica-based microsponge technology designed to encapsulate and gradually release active pharmaceutical ingredients in the skin.

Its marketed products include TWYNEO, a topical cream combining tretinoin and benzoyl peroxide for the treatment of acne vulgaris, and EPSOLAY, a topical benzoyl peroxide cream for the treatment of inflammatory lesions associated with rosacea. Both products have received approval from the U.S. Food and Drug Administration.

Sol-Gel Technologies is headquartered in Ness Ziona, Israel, and has focused primarily on the U.S. dermatology market through commercialization and licensing arrangements. The company was founded in 1997 and continues to develop additional topical therapies for dermatological conditions. Its leadership includes founder and Chief Executive Officer Dr. Alon Seri-Levy.

View Sol-Gel Technologies Profile
Earnings Tools